Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 169,117 | 27,963 | 0 | 0 | 22,334 |
| Cost of Goods | 15,277 | 846 | N/A | N/A | 5,742 |
| Gross Profit | 153,840 | 27,117 | N/A | N/A | 16,592 |
| Operating Expenses | 196,516 | 165,812 | 98,561 | 85,546 | 11,519 |
| Operating Income | -42,399 | -137,849 | -98,561 | -85,546 | 5,815 |
| Interest Expense | 10,830 | 9,886 | 12,342 | 9,942 | 12,994 |
| Other Income | 4,150 | -13,042 | -536 | 2,343 | 2,097 |
| Pre-tax Income | -49,079 | -160,777 | -111,439 | -93,145 | -5,082 |
| Income Tax | -247 | -501 | 26,025 | -15,816 | -12,110 |
| Net Income Continuous | -48,832 | -160,276 | -137,464 | -77,329 | 7,028 |
| Net Income | $-48,832 | $-160,276 | $-137,464 | $-77,329 | $7,028 |
| EPS Basic Total Ops | -0.51 | -2.00 | -2.29 | -1.32 | 0.13 |
| EPS Basic Continuous Ops | -0.51 | -2.00 | -2.29 | -1.32 | 0.13 |
| EPS Diluted Total Ops | -0.51 | -2.00 | -2.29 | -1.32 | 0.13 |
| EPS Diluted Continuous Ops | -0.51 | -2.00 | -2.29 | -1.32 | 0.13 |
| EPS Diluted Before Non-Recurring Items | -0.51 | -1.87 | -2.29 | -1.32 | -0.75 |
| EBITDA(a) | $-39,718 | $-136,083 | $-97,068 | $-84,731 | $7,505 |